We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$137M
Cap. Flow %
3.08%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,516
Reduced
1,175
Closed
233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.4M
2
JMBS icon
Janus Henderson Mortgage-Backed Securities ETF
JMBS
+$26.6M
3
CVBF icon
CVB Financial
CVBF
+$17.4M
4
AAPL icon
Apple
AAPL
+$16.9M
5
BINC icon
BlackRock Flexible Income ETF
BINC
+$15.6M

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$25.2M
2
IGEB icon
iShares Investment Grade Systematic Bond ETF
IGEB
+$18.5M
3
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$6.13M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.91M
5
SSNC icon
SS&C Technologies
SSNC
+$3.41M

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Healthcare 9.75%
3 Financials 7.52%
4 Communication Services 4.86%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARQT icon
3351
Arcutis Biotherapeutics
ARQT
$3.18B
$219 ﹤0.01%
14
-14
-50% -$197
PRME icon
3352
Prime Medicine
PRME
$559M
$219 ﹤0.01%
+110
New +$281
GBTG icon
3353
American Express Global Business Travel
GBTG
$4.94B
$218 ﹤0.01%
+30
New +$253
SILA
3354
DELISTED
Sila Realty Trust
SILA
$214 ﹤0.01%
+8
New +$200
MAX icon
3355
MediaAlpha
MAX
$821M
$213 ﹤0.01%
23
+6
+35% +$64
HOV icon
3356
Hovnanian Enterprises
HOV
$807M
$209 ﹤0.01%
2
– –
EVLV icon
3357
Evolv Technologies
EVLV
$1.1B
$206 ﹤0.01%
+66
New +$232
ORKA
3358
Oruka Therapeutics
ORKA
$5.96B
$205 ﹤0.01%
20
– –
LE icon
3359
Lands' End
LE
$403M
$204 ﹤0.01%
+20
New +$238
FWRD icon
3360
Forward Air
FWRD
$654M
$201 ﹤0.01%
10
-65
-87% -$1.79K
ALT icon
3361
Altimmune
ALT
$599M
$200 ﹤0.01%
40
– –
IRON icon
3362
Disc Medicine
IRON
$2.97B
$199 ﹤0.01%
4
+3
+300% +$167
KRBN icon
3363
KraneShares Global Carbon Strategy ETF
KRBN
$143M
$198 ﹤0.01%
7
– –
AEVAW
3364
DELISTED
Aeva Technologies Warrants
AEVAW
$198 ﹤0.01%
2,500
– –
ELVN icon
3365
Enliven Therapeutics
ELVN
$4.43B
$197 ﹤0.01%
10
+6
+150% +$129
CENTA icon
3366
Central Garden & Pet Co Class A
CENTA
$2.44B
$196 ﹤0.01%
6
-7
-54% -$222
VVX icon
3367
V2X
VVX
$2.65B
$196 ﹤0.01%
4
-3
-43% -$147
RLAY icon
3368
Relay Therapeutics
RLAY
$4.33B
$194 ﹤0.01%
+74
New +$290
HLMN icon
3369
Hillman Solutions
HLMN
$1.79B
$193 ﹤0.01%
22
-33
-60% -$321
HCSG icon
3370
Healthcare Services Group
HCSG
$1.53B
$192 ﹤0.01%
19
– –
DLX icon
3371
Deluxe
DLX
$1.15B
$190 ﹤0.01%
12
-20
-63% -$379
FIP icon
3372
FTAI Infrastructure
FIP
$505M
$190 ﹤0.01%
42
+30
+250% +$187
LPL icon
3373
LG Display
LPL
$3.3B
$190 ﹤0.01%
61
– –
JANX icon
3374
Janux Therapeutics
JANX
$967M
$189 ﹤0.01%
7
+5
+250% +$188
JOE icon
3375
St. Joe Company
JOE
$3.83B
$188 ﹤0.01%
4
– –
133 134
135
136 137

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $137M of net new capital in Q1 2025, opening 225 new positions and adding to 1,516 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.